Assessing the Quality of Life and Social Support in Age-Related Macular Degeneration Patients

NCT05427994 | Completed

• 1 other identifier: 1394
• Study Type: observational
• Target: 458
• Locations: 1 country
• Sites: 2

Brief Summary

The aim of this study is to evaluate the quality of life of AMD patients related to vision using the short version of the National Eye Institute Visual Function Questionnaire (NEI-VFQ-25), patients' social support, and their relationship with demographic and clinical variables.

Conditions

Age-Related Macular Degeneration

Keywords

age-related macular degeneration; quality of life; social support; reliability of social support; vision related quality of life

Outcome Measures

Primary Outcomes (1)

• Quality of life of AMD patients

  Vision related Quality of life (QOL) of AMD patients related to vision assessed by NEI-VFQ-25 total score at the recruitment. NEI-VFQ-25 has 38 questions with multiple choice answers, each rated 0,25, 50, 75 or 100. The overall score is measured as a mean of all answers

  at the recruitment to the study

Secondary Outcomes (3)

• Social Support

  at the recruitment to the study

• Reliability of Social Support

  at the recruitment to the study

• Relationship between QOL and social support

  at the recruitment to the study

Study Arms (1)

Patients with age-related macular degeneration

Patients with age-related macular degeneration who fill out the quality of life questionnaire, and answer questions about social support and reliability of social support

Other: National Eye Institute Visual Function Questionnaire

Interventions

National Eye Institute Visual Function Questionnaire OTHER

National Eye Institute Visual Function Questionnaire (NEI-VFQ-25) measures the quality of life related to vision. This questionnaire has been validated for use on low vision patients.

Also known as: NEI-VFQ-25

Patients with age-related macular degeneration

Eligibility Criteria

• Age: 30 Years - 90 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients with diagnosed age-related macular degeneration

You may qualify if:

• age-related macular degeneration; ability to speak and understand Russian and/or Kazakh language; willingness to participate

You may not qualify if:

• Presence of glaucoma, cataracts of grade 2 or more according to the Lens Opacities Classification System (LOCS) III, and the presence of corneal opacities or any other retinal diseases

Sponsors & Collaborators

• Asfendiyarov Kazakh National Medical University: lead

Study Sites (2)

Kazakh Scientific - Research Institute of Eye Diseases

Almaty, 050012, Kazakhstan

Location

Medical Centre Hospital of President'S Affairs Administration of the Republic of Kazakhstan

Astana, 010000, Kazakhstan

Location

Related Publications (1)

• Ismayilova I, Turdaliyeva B, Aldasheva N, Veselovskaya N. Assessing the quality of life in age-related macular degeneration patients: a cross-sectional study in Kazakhstan. Acta Biomed. 2022 Dec 16;93(6):e2022299. doi: 10.23750/abm.v93i6.13580.

  PMID: 36533748 DERIVED

MeSH Terms

Conditions

Macular Degeneration

Condition Hierarchy (Ancestors)

Retinal Degeneration; Retinal Diseases; Eye Diseases

Study Officials

• Inara Isamyilova, PhD

  Asfendiyarov Kazakh National Medical University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: June 15, 2022
• First Posted: June 22, 2022
• Study Start: April 5, 2021
• Primary Completion: July 27, 2022
• Study Completion: July 27, 2022
• Last Updated: September 1, 2022

Record last verified: 2022-08

Data Sharing

• IPD Sharing: Will not share

Locations

KA (2)